Drug · DIN 02526794
VRAYLAR
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 5, 2024; first marketed June 24, 2022.
- Drug Identification Number (DIN)
- 02526794
- Company (DIN owner)
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Cariprazine N05AX15
- Class
- Human
- Record last updated
- July 14, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CARIPRAZINE (CARIPRAZINE HYDROCHLORIDE) | 1.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 9, 2022: NOC 28916New Drug Submission (NDS) · Administrative: Merger/Buy-out
- April 22, 2022: NOC 28008New Drug Submission (NDS)
Other DINs named VRAYLAR
- DIN 02526808 · Marketed
- DIN 02526816 · Marketed
- DIN 02526824 · Marketed